Oncology

Aspirin and COX-1 inhibitors may reduce cancer metastasis by enhancing T cell immunity, offering a new treatment approach.

Nivolumab enhances chemotherapy efficacy in high-risk ER+/HER2− breast cancer, offering new treatment potential for early-stage patients.

A recent study has revealed a significant disparity in COVID-19 mortality rates between Non-Hispanic Black and Non-Hispanic White cancer patients….

A study on lung cancer treatment shows that combining photodynamic therapy (PDT) with cisplatin significantly inhibits tumor growth, promoting apoptosis in lung adenocarcinoma cells.

Elevated salivary microvesicles are linked to non-healing oral ulcers and oral cancer, potentially aiding in early diagnosis.

The MITO 40 study, presented at ESGO 2025, highlights promising results for Niraparib as a maintenance treatment in ovarian cancer patients with no residual disease post-surgery.

Rucaparib showed longer progression-free survival, chemotherapy-free interval, and time to first subsequent treatment in advanced ovarian cancer patients, according to updated results from the ATHENA-MONO study.

ESGO 2025 study reveals overestimation of preoperative tumour size in stage IB2 cervical cancer, influencing adjuvant therapy decisions.